Article
Adoptive immunotherapy for cancer: the next generation of gene‐engineered immune cells
17 Sept 2009
Abstract excerpt
Adoptive cellular immunotherapy involving transfer of tumor-reactive T cells has shown some notable antitumor responses in a minority of cancer patients. In particular, transfer of tumor-infiltrating lymphocytes has resulted in long-term objective responses in patients with advanced melanoma. However, the inability to isolate sufficient numbers of tumor-specific T cells from most malignancies has restricted the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
